IL236901B - Expression of variable strains of nme and repression - Google Patents

Expression of variable strains of nme and repression

Info

Publication number
IL236901B
IL236901B IL236901A IL23690115A IL236901B IL 236901 B IL236901 B IL 236901B IL 236901 A IL236901 A IL 236901A IL 23690115 A IL23690115 A IL 23690115A IL 236901 B IL236901 B IL 236901B
Authority
IL
Israel
Prior art keywords
suppression
variant species
species expression
nme
nme variant
Prior art date
Application number
IL236901A
Other languages
English (en)
Hebrew (he)
Other versions
IL236901A0 (en
Original Assignee
Minerva Biotechnologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/060684 external-priority patent/WO2013059373A2/en
Application filed by Minerva Biotechnologies Corp filed Critical Minerva Biotechnologies Corp
Publication of IL236901A0 publication Critical patent/IL236901A0/en
Publication of IL236901B publication Critical patent/IL236901B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL236901A 2012-07-24 2015-01-25 Expression of variable strains of nme and repression IL236901B (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201261675292P 2012-07-24 2012-07-24
US201261677442P 2012-07-30 2012-07-30
US201261679021P 2012-08-02 2012-08-02
US201261683155P 2012-08-14 2012-08-14
US201261684654P 2012-08-17 2012-08-17
US201261693712P 2012-08-27 2012-08-27
PCT/US2012/060684 WO2013059373A2 (en) 2011-10-17 2012-10-17 Media for stem cell proliferation and induction
PCT/US2013/051899 WO2014018679A2 (en) 2012-07-24 2013-07-24 Nme variant species expression and suppression

Publications (2)

Publication Number Publication Date
IL236901A0 IL236901A0 (en) 2015-03-31
IL236901B true IL236901B (en) 2021-03-25

Family

ID=49997968

Family Applications (1)

Application Number Title Priority Date Filing Date
IL236901A IL236901B (en) 2012-07-24 2015-01-25 Expression of variable strains of nme and repression

Country Status (9)

Country Link
US (2) US20150203823A1 (enExample)
EP (2) EP2877586A4 (enExample)
JP (3) JP6546087B2 (enExample)
CN (2) CN111849874A (enExample)
AU (2) AU2013295811A1 (enExample)
CA (1) CA2880010A1 (enExample)
IL (1) IL236901B (enExample)
SG (2) SG11201606118SA (enExample)
WO (1) WO2014018679A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2830503A1 (en) 2011-03-17 2012-09-20 Minerva Biotechnologies Corporation Method for making pluripotent stem cells
CA2852244C (en) 2011-10-17 2023-10-17 Minerva Biotechnologies Corporation Media for stem cell proliferation and induction
JP6640086B2 (ja) * 2013-08-12 2020-02-05 ミネルバ バイオテクノロジーズ コーポレーション 腫瘍成長を増強する方法
SG11201608389RA (en) * 2014-04-07 2016-11-29 Minerva Biotechnologies Corp Anti-nme antibody
US11746159B2 (en) 2015-02-10 2023-09-05 Minerva Biotechnologies Corporation Humanized anti-MUC1* antibodies
CN109081863A (zh) * 2018-08-01 2018-12-25 西北民族大学 抗癌活性物质放线菌素fgr的分离鉴定方法
CA3128384A1 (en) 2019-02-04 2020-08-13 Minerva Biotechnologies Corporation Anti-nme antibody and method of treating cancer or cancer metastasis
CA3181655A1 (en) 2020-06-08 2021-12-16 Minerva Biotechnologies Corporation Anti-nme antibody and method of treating cancer or cancer metastasis
US20230242678A1 (en) 2020-06-26 2023-08-03 Minerva Biotechnologies Corporation Anti-nme antibody and method of treating cancer or cancer metastasis
IL316221A (en) 2022-04-12 2024-12-01 Minerva Biotechnologies Corp Anti-MUC1* variant antibodies and their uses

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005507876A (ja) * 2001-09-05 2005-03-24 ミナーバ バイオテクノロジーズ コーポレイション 癌を治療する組成物および方法
EP1375661A1 (en) * 2002-06-17 2004-01-02 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam The role of the N-myc - nm23H1/nm23H2 - cdc42 pathway in proliferation, differentiation and treatment of cancer
CN101273060A (zh) * 2005-06-24 2008-09-24 美国政府（由卫生和人类服务部、国立卫生研究院的部长所代表） 通过靶向肿瘤坏死因子受体的前配体装配域(plad)来缓解炎性关节炎
JP2008099662A (ja) * 2006-09-22 2008-05-01 Institute Of Physical & Chemical Research 幹細胞の培養方法
WO2008067065A2 (en) * 2006-10-19 2008-06-05 Shiv Srivastava Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
CN101652469B (zh) * 2006-12-06 2014-04-16 米纳瓦生物技术公司 用于鉴定和操作细胞的方法
US8273722B2 (en) 2007-07-13 2012-09-25 Dharmacon, Inc. Enhanced biotherapeutic production using inhibitory RNA
JP2012505636A (ja) * 2008-10-09 2012-03-08 ミネルバ バイオテクノロジーズ コーポレーション 細胞において多能性を誘導する方法
CA2767164C (en) * 2009-06-11 2019-10-15 Cynthia Bamdad Culturing embryonic stem cells, embryonic stem-like cells or induced pluripotent stem cells with a muc1 or muc1* ligand
EP2582399A4 (en) * 2010-06-16 2015-04-15 Minerva Biotechnologies Corp NEW PROGRAMMING OF CANCER CELLS
AU2013289913A1 (en) * 2012-07-13 2015-03-05 Minerva Biotechnologies Corporation Method for inducing cells to less mature state

Also Published As

Publication number Publication date
AU2019203098B2 (en) 2021-04-08
CN111849874A (zh) 2020-10-30
AU2019203098A1 (en) 2019-05-23
JP2015529454A (ja) 2015-10-08
WO2014018679A2 (en) 2014-01-30
IL236901A0 (en) 2015-03-31
US20150203823A1 (en) 2015-07-23
CN104995518A (zh) 2015-10-21
SG11201606118SA (en) 2016-08-30
EP4206318A1 (en) 2023-07-05
JP6546087B2 (ja) 2019-07-17
CA2880010A1 (en) 2014-01-30
JP7386210B2 (ja) 2023-11-24
AU2013295811A1 (en) 2015-03-12
EP2877586A2 (en) 2015-06-03
JP2021192614A (ja) 2021-12-23
SG10201700593YA (en) 2017-03-30
JP2019141100A (ja) 2019-08-29
WO2014018679A3 (en) 2015-05-07
US20230049461A1 (en) 2023-02-16
EP2877586A4 (en) 2016-02-17

Similar Documents

Publication Publication Date Title
IL235826A0 (en) Diazaspirocycloalkane and azaspirocycloalkane
IL236901A0 (en) Expression of variable strains of nme and repression
AP2014007824A0 (en) Pesticidal compositions and processes related thereto
ZA201408594B (en) Xylitol-based anti-mucosal compositions and related methods and compositions
GB201318361D0 (en) Content protection
AP2014007823A0 (en) Pesticidal compositions and processes related thereto
GB201223022D0 (en) Natural language processing
GB201208548D0 (en) Compound and method
GB201216649D0 (en) Agents and methods
EP2806872A4 (en) BENDAMUSTIN COMPOSITIONS AND RELATED METHODS
IL233605A0 (en) Compounds and methods for the treatment of Candida and Aspergillus fungi
IL219244A0 (en) Splitting of user-lists
ZA201405393B (en) Aryloxyacetamide compound and pesticide
GB201315350D0 (en) Methods and compositions
GB201315347D0 (en) Methods and compositions
GB201210398D0 (en) Crop enhancement
IL236154A0 (en) compound and method
GB201319388D0 (en) Rope protector
GB201213778D0 (en) Process and dressng
GB201207907D0 (en) Treatment of depression
GB2506242B (en) Pillowrap - pillow protector
SMT201700322T1 (it) Composizione dermoprotettiva e dermoequilibrante
GB201222736D0 (en) Composition and process
GB201219700D0 (en) Language buddy
GB201212715D0 (en) Treatment of fungal infections

Legal Events

Date Code Title Description
FF Patent granted